INM: InMed Pharmaceuticals Inc. Stocks News on November 16, 2025

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

INM

Newsfile

10 days ago

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

INM

Newsfile

a month ago

InMed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

INM

Newsfile

a month ago

InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

INM

Newsfile

5 months ago

InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

INM

Newsfile

5 months ago

InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

INM

MT Newswires

5 months ago

InMed Says Preclinical Data Show INM-901 'Significantly' Reduces Neuroinflammation; Shares Jump

INM

MT Newswires

5 months ago

InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study

InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA

INM

Newsfile

5 months ago

InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA

INM

MT Newswires

5 months ago

InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Second Quarter 2025 Earnings: US$3.65 loss per share (vs US$3.71 loss in 2Q 2024)

INM

Simply Wall St.

9 months ago

InMed Pharmaceuticals Second Quarter 2025 Earnings: US$3.65 loss per share (vs US$3.71 loss in 2Q 2024)

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

INM

Newsfile

9 months ago

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

INM

Newsfile

9 months ago

InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds

INM

Newsfile

10 months ago

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds

INM

MT Newswires

10 months ago

InMed Pharmaceuticals Says Alzheimer's Disease Trial Shows Significant Reduction in Neuroinflammation

InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study

INM

Newsfile

10 months ago

InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study

InMed Announces Results of 2024 Annual General Meeting

INM

Newsfile

a year ago

InMed Announces Results of 2024 Annual General Meeting

InMed Enters Into Standby Equity Purchase Agreement

INM

Newsfile

a year ago

InMed Enters Into Standby Equity Purchase Agreement

InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System

INM

Newsfile

a year ago

InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System

INM

Newsfile

a year ago

InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules

INM

Newsfile

a year ago

InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules

InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules

INM

Newsfile

a year ago

InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules

InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease

INM

Newsfile

a year ago

InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease

InMed to Participate in Fierce Biotech Webinar on Neuroinflammation in Alzheimer's Disease

INM

Newsfile

a year ago

InMed to Participate in Fierce Biotech Webinar on Neuroinflammation in Alzheimer's Disease

InMed Appoints Dr. Barry Greenberg, Johns Hopkins University School of Medicine, to its Scientific Advisory Board

INM

Newsfile

a year ago

InMed Appoints Dr. Barry Greenberg, Johns Hopkins University School of Medicine, to its Scientific Advisory Board

InMed Pharmaceuticals Reports Full Year Fiscal 2024 Financial Results and Provides Business Update

INM

Newsfile

a year ago

InMed Pharmaceuticals Reports Full Year Fiscal 2024 Financial Results and Provides Business Update

InMed Receives NASDAQ Delisting Notice, and Confirms it has Filed an Appeal and Obtained a Panel Hearing Date

INM

Newsfile

a year ago

InMed Receives NASDAQ Delisting Notice, and Confirms it has Filed an Appeal and Obtained a Panel Hearing Date

InMed Pharmaceuticals Strengthens Patent Portfolio with Issuance of Three U.S. Patents

INM

Newsfile

a year ago

InMed Pharmaceuticals Strengthens Patent Portfolio with Issuance of Three U.S. Patents

InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer's Disease

INM

Newsfile

a year ago

InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer's Disease

InMed Pharmaceuticals Announces Favorable Behavioral Outcomes with INM-901 in Long-Term Preclinical Alzheimer's Disease Study, Confirming Previous Short-Term Pilot Study Data

INM

Newsfile

a year ago

InMed Pharmaceuticals Announces Favorable Behavioral Outcomes with INM-901 in Long-Term Preclinical Alzheimer's Disease Study, Confirming Previous Short-Term Pilot Study Data

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

INM

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

InMed to Present at the Emerging Growth Conference

INM

Newsfile

a year ago

InMed to Present at the Emerging Growth Conference

INM

Business Wire

a year ago

Dstny honored with 'Employee Wellbeing Award'

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

INM

PR Newswire

a year ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

INM

GlobeNewswire

a year ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

INM

Business Wire

a year ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

INM

GlobeNewswire

a year ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

INM

Newsfile

a year ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

INM

Business Wire

a year ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

INM

Journal-News, Hamilton, Ohio

a year ago

Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

INM

TechCrunch

a year ago

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

INM

Motley Fool

a year ago

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Italian energy company targets Britain for fleet of 20 mini-nukes

INM

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

INM

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

INM

Bloomberg

a year ago

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

INM

Simply Wall St.

a year ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

INM

Simply Wall St.

a year ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Lotto 6/49 - $64 million up for grabs in the next draw!

INM

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

INM

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

INM

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

INM

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

INM

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

INM

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

INM

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

INM

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake

INM

Simply Wall St.

a year ago

With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake

INM

Motley Fool

a year ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

INM

Motley Fool

a year ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)

INM

Simply Wall St.

a year ago

Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)

INM

Motley Fool

a year ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

INM

AFP

a year ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

INM

Motley Fool

a year ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

INM

GuruFocus.com

a year ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

INM

Newsfile

2 years ago

InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board

INM

Newsfile

2 years ago

InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board

InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration

INM

Newsfile

2 years ago

InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration

InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies

INM

Newsfile

2 years ago

InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies

InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance

INM

Newsfile

2 years ago

InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance

InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update

INM

Newsfile

2 years ago

InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update

InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer

INM

Newsfile

2 years ago

InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer

BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting

INM

GlobeNewswire

2 years ago

BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting

Dolphin Entertainment Congratulates The Door’s Longtime Client, TV Personality Rachael Ray on Her Newly Announced Partnership with A+E Networks

INM

ACCESSWIRE

2 years ago

Dolphin Entertainment Congratulates The Door’s Longtime Client, TV Personality Rachael Ray on Her Newly Announced Partnership with A+E Networks

Abits Group Inc Announces Operational Updates For The Quarter Ended December 31, 2023

INM

GlobeNewswire

2 years ago

Abits Group Inc Announces Operational Updates For The Quarter Ended December 31, 2023

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

INM

InvestorPlace

2 years ago

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

INM

Zacks

2 years ago

New Strong Buy Stocks for January 26th

BayFirst Financial Corp. Reports Fourth Quarter 2023 Results; Highlighted by Net Interest Margin Expansion and Strong SBA Loan Originations

INM

GlobeNewswire

2 years ago

BayFirst Financial Corp. Reports Fourth Quarter 2023 Results; Highlighted by Net Interest Margin Expansion and Strong SBA Loan Originations

Dolphin Entertainment Congratulates 42West and its Clients for Securing 24 Nominations for the 96th Academy Awards

INM

ACCESSWIRE

2 years ago

Dolphin Entertainment Congratulates 42West and its Clients for Securing 24 Nominations for the 96th Academy Awards

Moleculin Announces 2023 Year-End Annamycin Clinical Trials Preliminary Data and 2024 Expectations for Multiple Data Readouts and Transition to Pivotal Phase 2B/3

INM

PR Newswire

2 years ago

Moleculin Announces 2023 Year-End Annamycin Clinical Trials Preliminary Data and 2024 Expectations for Multiple Data Readouts and Transition to Pivotal Phase 2B/3

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference

INM

GlobeNewswire

2 years ago

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference

INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

INM

ACCESSWIRE

2 years ago

INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

INM

Newsfile

2 years ago

InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET

WISeKey’s Subsidiary, WISe.ART, a Digital Assets Leading Platform in the Field of Digital Art and Luxury Collectibles,

INM

GlobeNewswire

2 years ago

WISeKey’s Subsidiary, WISe.ART, a Digital Assets Leading Platform in the Field of Digital Art and Luxury Collectibles,

INM

GlobeNewswire

2 years ago

SEALSQ Launches SEALCOIN at Davos Event

Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug

INM

PR Newswire

2 years ago

Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug

CPI Aerostructures Appoints Ross Johnson to Leadership Team as Vice President, Program Management

INM

GlobeNewswire

2 years ago

CPI Aerostructures Appoints Ross Johnson to Leadership Team as Vice President, Program Management

InMed Pharmaceuticals Provides Business Update and Milestones for 2024

INM

Newsfile

2 years ago

InMed Pharmaceuticals Provides Business Update and Milestones for 2024

INM

Investing.com

2 years ago

4 big dividends this week: Lennar hikes dividend, announces $5B buyback

Office Properties' Dividend Gets Whacked: Isolated Case Or The Start of A Trend?

INM

Benzinga

2 years ago

Office Properties' Dividend Gets Whacked: Isolated Case Or The Start of A Trend?

SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference

INM

PR Newswire

2 years ago

SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference

$Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients$

INM

GlobeNewswire

2 years ago

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients

Rent the Runway Lays Off 10 Percent of Corporate Workforce

INM

WWD

2 years ago

Rent the Runway Lays Off 10 Percent of Corporate Workforce

Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution

INM

InvestorPlace

2 years ago

Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution

Creative Realities to Debut as Exhibitors at NRF 2024: Retail’s Big Show

INM

GlobeNewswire

2 years ago

Creative Realities to Debut as Exhibitors at NRF 2024: Retail’s Big Show

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform

INM

GlobeNewswire

2 years ago

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform

Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023

INM

GlobeNewswire

2 years ago

Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023

Faraday Future Delivers an FF 91 2.0 to its Newest User, Jim Gao, Vice President of FF’s Intelligent Internet Application Service Platform, Marking Ten Deliveries by the Company in 2023

INM

Business Wire

2 years ago

Faraday Future Delivers an FF 91 2.0 to its Newest User, Jim Gao, Vice President of FF’s Intelligent Internet Application Service Platform, Marking Ten Deliveries by the Company in 2023

Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote "FOR" All Proxy Proposals at the Special Meeting to be held on January 10, 2024

INM

PR Newswire

2 years ago

Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote "FOR" All Proxy Proposals at the Special Meeting to be held on January 10, 2024

Meihua International Medical Technologies Co., Ltd. Announces Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering

INM

PR Newswire

2 years ago

Latest InMed Pharmaceuticals Inc. (INM) News on November 16, 2025

Share on Social Networks: